Clinical Trials Directory

Trials / Terminated

TerminatedNCT01412918

Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression

Clinical Evaluation of the Inhibitor Tinnitus Treatment Masking Device & SCN9 Gene Expression

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate the effectiveness of the Inhibitor™ Tinnitus Masking Device. To determine if there is a higher incident of expression of the sodium channel, voltage gated, type IX alpha subunit (SCN9) gene in those subjects with disturbing tinnitus than subjects that are not disturbed by tinnitus.

Detailed description

Up to 50 million Americans have tinnitus on a regular basis with between 2-3 million suffering from tinnitus where it affects daily living. The Inhibitor™ Tinnitus Masking Device is a new tinnitus treatment device recently available in the United States for use of temporary relief of tinnitus. The device emits an ultra high frequency sound for 60 seconds via bone conduction when applied to the mastoid. Patients reporting tinnitus will be provided the opportunity to demonstrate the device to observe any changes in their tinnitus. The device may be demonstrated up to 5 times. The investigators will be recording the the degree and duration of change in tinnitus perception following treatment with the Inhibitor™ Tinnitus Masking Device. Patients may provide a genetic sample (typically via saliva sample) to look for expression of a particular genetic marker that may be associated with tinnitus. The investigators will be collect samples from both people with tinnitus and those without tinnitus to use as a control.

Conditions

Interventions

TypeNameDescription
DEVICEThe Inhibitor™ Tinnitus Masking DeviceThe Inhibitor™ Tinnitus Masking Device

Timeline

Start date
2011-09-01
Primary completion
2013-09-01
Completion
2014-01-01
First posted
2011-08-09
Last updated
2016-02-29
Results posted
2016-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01412918. Inclusion in this directory is not an endorsement.